A citation-based method for searching scientific literature


List of co-cited articles
467 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
C Davies, J Godwin, R Gray, M Clarke, D Cutter, S Darby, P McGale, H C Pan, C Taylor, Y C Wang,[...]. Lancet 2011
17

Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.
Marco Colleoni, Shari Gelber, Aron Goldhirsch, Stefan Aebi, Monica Castiglione-Gertsch, Karen N Price, Alan S Coates, Richard D Gelber. J Clin Oncol 2006
178
10


Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Christina Davies, Hongchao Pan, Jon Godwin, Richard Gray, Rodrigo Arriagada, Vinod Raina, Mirta Abraham, Victor Hugo Medeiros Alencar, Atef Badran, Xavier Bonfill,[...]. Lancet 2013
10

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
9


Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998
9

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
R Peto, C Davies, J Godwin, R Gray, H C Pan, M Clarke, D Cutter, S Darby, P McGale, C Taylor,[...]. Lancet 2012
9

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
8


Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L Baehner, Drew Watson, John Bryant,[...]. J Clin Oncol 2006
7

A gene-expression signature as a predictor of survival in breast cancer.
Marc J van de Vijver, Yudong D He, Laura J van't Veer, Hongyue Dai, Augustinus A M Hart, Dorien W Voskuil, George J Schreiber, Johannes L Peterse, Chris Roberts, Matthew J Marton,[...]. N Engl J Med 2002
7


A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
Beat Thürlimann, Aparna Keshaviah, Alan S Coates, Henning Mouridsen, Louis Mauriac, John F Forbes, Robert Paridaens, Monica Castiglione-Gertsch, Richard D Gelber, Manuela Rabaglio,[...]. N Engl J Med 2005
6

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.
Ann H Partridge, Philip S Wang, Eric P Winer, Jerry Avorn. J Clin Oncol 2003
504
6

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
Dawn L Hershman, Lawrence H Kushi, Theresa Shao, Donna Buono, Aaron Kershenbaum, Wei-Yann Tsai, Louis Fehrenbacher, Scarlett Lin Gomez, Sunita Miles, Alfred I Neugut. J Clin Oncol 2010
558
6


A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
6


Aromatase inhibitors in breast cancer.
Ian E Smith, Mitch Dowsett. N Engl J Med 2003
604
6

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.
I Craig Henderson, Donald A Berry, George D Demetri, Constance T Cirrincione, Lori J Goldstein, Silvana Martino, James N Ingle, M Robert Cooper, Daniel F Hayes, Katherine H Tkaczuk,[...]. J Clin Oncol 2003
899
5

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
5


Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.
B Fisher, C Redmond, R Poisson, R Margolese, N Wolmark, L Wickerham, E Fisher, M Deutsch, R Caplan, Y Pilch. N Engl J Med 1989
5

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.
Marc Buyse, Sherene Loi, Laura van't Veer, Giuseppe Viale, Mauro Delorenzi, Annuska M Glas, Mahasti Saghatchian d'Assignies, Jonas Bergh, Rosette Lidereau, Paul Ellis,[...]. J Natl Cancer Inst 2006
801
5

Gene expression profiling predicts clinical outcome of breast cancer.
Laura J van 't Veer, Hongyue Dai, Marc J van de Vijver, Yudong D He, Augustinus A M Hart, Mao Mao, Hans L Peterse, Karin van der Kooy, Matthew J Marton, Anke T Witteveen,[...]. Nature 2002
5

Combination chemotherapy as an adjuvant treatment in operable breast cancer.
G Bonadonna, E Brusamolino, P Valagussa, A Rossi, L Brugnatelli, C Brambilla, M De Lena, G Tancini, E Bajetta, R Musumeci,[...]. N Engl J Med 1976
5

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.
B Fisher, P Carbone, S G Economou, R Frelick, A Glass, H Lerner, C Redmond, M Zelen, P Band, D L Katrych,[...]. N Engl J Med 1975
749
5


Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.
Xiaojiang Cui, Rachel Schiff, Grazia Arpino, C Kent Osborne, Adrian V Lee. J Clin Oncol 2005
350
5

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Grazia Arpino, Heidi Weiss, Adrian V Lee, Rachel Schiff, Sabino De Placido, C Kent Osborne, Richard M Elledge. J Natl Cancer Inst 2005
371
5

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Meredith M Regan, Patrick Neven, Anita Giobbie-Hurder, Aron Goldhirsch, Bent Ejlertsen, Louis Mauriac, John F Forbes, Ian Smith, István Láng, Andrew Wardley,[...]. Lancet Oncol 2011
269
5

Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.
Sandra M Swain, Jong-Hyeon Jeong, Charles E Geyer, Joseph P Costantino, Eduardo R Pajon, Louis Fehrenbacher, James N Atkins, Jonathan Polikoff, Victor G Vogel, John K Erban,[...]. N Engl J Med 2010
227
5

Adjuvant ovarian suppression in premenopausal breast cancer.
Prudence A Francis, Meredith M Regan, Gini F Fleming, István Láng, Eva Ciruelos, Meritxell Bellet, Hervé R Bonnefoi, Miguel A Climent, Gian Antonio Da Prada, Harold J Burstein,[...]. N Engl J Med 2015
426
5


Early discontinuation of tamoxifen: a lesson for oncologists.
Thomas I Barron, Róisín Connolly, Kathleen Bennett, John Feely, M John Kennedy. Cancer 2007
232
4

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.
R Charles Coombes, Emma Hall, Lorna J Gibson, Robert Paridaens, Jacek Jassem, Thierry Delozier, Stephen E Jones, Isabel Alvarez, Gianfilippo Bertelli, Olaf Ortmann,[...]. N Engl J Med 2004
4

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer.
C McCowan, J Shearer, P T Donnan, J A Dewar, M Crilly, A M Thompson, T P Fahey. Br J Cancer 2008
245
4

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.
D J Slamon, G M Clark, S G Wong, W J Levin, A Ullrich, W L McGuire. Science 1987
4

Weekly paclitaxel in the adjuvant treatment of breast cancer.
Joseph A Sparano, Molin Wang, Silvana Martino, Vicky Jones, Edith A Perez, Tom Saphner, Antonio C Wolff, George W Sledge, William C Wood, Nancy E Davidson. N Engl J Med 2008
643
4

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett, J F Forbes, G Hoctin-Boes, J Houghton, G Y Locker, J S Tobias. Lancet 2005
4

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
Paul E Goss, James N Ingle, Silvana Martino, Nicholas J Robert, Hyman B Muss, Martine J Piccart, Monica Castiglione, Dongsheng Tu, Lois E Shepherd, Kathleen I Pritchard,[...]. N Engl J Med 2003
4

Adherence to tamoxifen over the five-year course.
Timothy L Lash, Matthew P Fox, Jennifer L Westrup, Aliza K Fink, Rebecca A Silliman. Breast Cancer Res Treat 2006
253
4

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer.
V Ziller, M Kalder, U-S Albert, W Holzhauer, M Ziller, U Wagner, P Hadji. Ann Oncol 2009
202
4

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
Giuseppe Viale, Meredith M Regan, Eugenio Maiorano, Mauro G Mastropasqua, Patrizia Dell'Orto, Birgitte Bruun Rasmussen, Johnny Raffoul, Patrick Neven, Zsolt Orosz, Stephen Braye,[...]. J Clin Oncol 2007
321
4





Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.